Improved outcome for children and adolescent with acute lymphoblastic leukemia in the first decade of the 21st century: A report from the Slovak Republic.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neoplasma (Bratislava)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4149/neo_2015_098PMID 26278138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.

  2014influential reference
• Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?

  2014cited by this paper
• Expanding clinical trial networks in pediatric acute lymphoblastic leukemia.

  2014influential reference
• Acute lymphoblastic leukaemia.

  2013cited by this paper
• Development of treatment and clinical results in childhood acute myeloid leukemia in the Slovak Republic

  2013cited by this paper
• Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.

  2013cited by this paper
• Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.

  2012cited by this paper
• Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.

  2010cited by this paper
• ‘Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985–2000)’

  2010cited by this paper
• Minimal residual disease detection using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: Slovak experience.

  2010cited by this paper
• Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

  2010cited by this paper
• Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute Lymphoblastic leukaemia, 1980–2001

  2009cited by this paper
• Long-term Results Of the Pediatric Oncology Group Studies For Childhood Acute Lymphoblastic Leukemia 1984-2001: A Report From The Children’s Oncology Group

  2009cited by this paper
• Toward a total cure for acute lymphoblastic leukemia.

  2009cited by this paper
• Treatment of childhood acute lymphoblastic leukemia.

  2009cited by this paper
• Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?

  2008cited by this paper
• Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

  2008cited by this paper
• Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.

  2008cited by this paper
• Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

  2007cited by this paper
• Treatment of Childhood Acute Lymphoblastic Leukemia

  2002cited by this paper
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995

  2000cited by this paper
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

  2000cited by this paper
• Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.

  1996cited by this paper
• Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

  1995cited by this paper
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

  1988cited by this paper
• Chemotherapy of acute lymphocytic leukemia of childhood

  1972cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the modified-CCG-1881 and CCG-1882 Protocols at Pediatric Center of Hue Central Hospital, Vietnam

  2019cites this paper
• Clinical impact of genomic analysis in children with B-acute lymphoblastic leukemia: A pilot study in Slovakia.

  2019cites this paper
• Early mortality in children with acute lymphoblastic leukemia in a developing country: the role of malnutrition at diagnosis. A multicenter cohort MIGICCL study

  2017cites this paper
• Leukemia Cutis Mimicking Kerion Celsi:A challenging Diagnosis for Clinicians

  2016cites this paper